North American Cooperative Group Research Efforts in Lung Cancer

G. M. Strauss, J. Herndon, M. A. Maddaus, D. W. Johnstone, E. A. Johnson, D. M. Watson, D. J. Sugarbaker, R. L. Schilsky, M. R. Green, Randomized Clinical Trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB Non-Small Cell Lung Cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633 Journal of Clinical Oncology. ,vol. 22, pp. 7019- 7019 ,(2004) , 10.1200/JCO.2004.22.14_SUPPL.7019

N. Thatcher, A. Chang, P. Parikh, K. Pemberton, V. Archer, Pr4 ISEL: A Phase III survival study comparing gefitinib (IRESSA) plus best supportive care (BSC) with placebo plus BSC, in patients with advanced non-small-cell lung cancer (NSCLC) who had received one or two prior chemotherapy regimens Lung Cancer. ,vol. 49, ,(2005) , 10.1016/S0169-5002(05)80130-8

Ming-Sound Tsao, Akira Sakurada, Jean-Claude Cutz, Chang-Qi Zhu, Suzanne Kamel-Reid, Jeremy Squire, Ian Lorimer, Tong Zhang, Ni Liu, Manijeh Daneshmand, Paula Marrano, Gilda da Cunha Santos, Alain Lagarde, Frank Richardson, Lesley Seymour, Marlo Whitehead, Keyue Ding, Joseph Pater, Frances A. Shepherd, Erlotinib in lung cancer - molecular and clinical predictors of outcome. The New England Journal of Medicine. ,vol. 353, pp. 133- 144 ,(2005) , 10.1056/NEJMOA050736

David R. Gandara, Kari Chansky, Kathy S. Albain, Bryan R. Leigh, Laurie E. Gaspar, Primo N. Lara, Howard Burris, Paul Gumerlock, J. Philip Kuebler, James D. Bearden, John Crowley, Robert Livingston, Consolidation Docetaxel After Concurrent Chemoradiotherapy in Stage IIIB Non–Small-Cell Lung Cancer: Phase II Southwest Oncology Group Study S9504 Journal of Clinical Oncology. ,vol. 21, pp. 2004- 2010 ,(2003) , 10.1200/JCO.2003.04.197

Timothy Winton, Robert Livingston, David Johnson, James Rigas, Michael Johnston, Charles Butts, Yvon Cormier, Glenwood Goss, Richard Inculet, Eric Vallieres, Willard Fry, Drew Bethune, Joseph Ayoub, Keyue Ding, Lesley Seymour, Barbara Graham, Ming-Sound Tsao, David Gandara, Kenneth Kesler, Todd Demmy, Frances Shepherd, Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer The New England Journal of Medicine. ,vol. 352, pp. 2589- 2597 ,(2005) , 10.1056/NEJMOA043623

Frances A. Shepherd, José Rodrigues Pereira, Tudor Ciuleanu, Eng Huat Tan, Vera Hirsh, Sumitra Thongprasert, Daniel Campos, Savitree Maoleekoonpiroj, Michael Smylie, Renato Martins, Maximiliano van Kooten, Mircea Dediu, Brian Findlay, Dongsheng Tu, Dianne Johnston, Andrea Bezjak, Gary Clark, Pedro Santabárbara, Lesley Seymour, Erlotinib in previously treated non-small-cell lung cancer. The New England Journal of Medicine. ,vol. 353, pp. 123- 132 ,(2005) , 10.1056/NEJMOA050753

Harvey B. Niell, James E. Herndon, Antonius A. Miller, Dorothy M. Watson, Alan B. Sandler, Karen Kelly, Randolph S. Marks, Micheal C. Perry, Rafat H. Ansari, Grefory Otterson, John Ellerton, Everett E. Vokes, Mark R. Green, Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive- stage small-cell lung cancer : Cancer and leukemia group B trial 9732 Journal of Clinical Oncology. ,vol. 23, pp. 3752- 3759 ,(2005) , 10.1200/JCO.2005.09.071

Fred R. Hirsch, Marileila Varella-Garcia, Jason McCoy, Howard West, Ana Carolina Xavier, Paul Gumerlock, Paul A. Bunn, Wilbur A. Franklin, John Crowley, David R. Gandara, Increased Epidermal Growth Factor Receptor Gene Copy Number Detected by Fluorescence In Situ Hybridization Associates With Increased Sensitivity to Gefitinib in Patients With Bronchioloalveolar Carcinoma Subtypes: A Southwest Oncology Group Study Journal of Clinical Oncology. ,vol. 23, pp. 6838- 6845 ,(2005) , 10.1200/JCO.2005.01.2823

K Kelly, LE Gaspar, K Chansky, KS Albain, J Crowley, DR Gandara, None, Low incidence of pneumonitis on SWOG 0023: A preliminary analysis of an ongoing phase III trial of concurrent chemoradiotherapy followed by consolidation docetaxel and gefitinib/placebo maintenance in patients with inoperable stage III non-small cell lung cancer Journal of Clinical Oncology. ,vol. 23, pp. 7058- 7058 ,(2005) , 10.1200/JCO.2005.23.16_SUPPL.7058

E. E. Vokes, J. E. Herndon, M. J. Kelley, D. Watson, M. G. Cicchetti, M. R. Green, Induction chemotherapy followed by concomitant chemoradiotherapy (CT/XRT) versus CT/XRT alone for regionally advanced unresectable non-small cell lung cancer (NSCLC): Initial analysis of a randomized phase III trial Journal of Clinical Oncology. ,vol. 22, pp. 7005- 7005 ,(2004) , 10.1200/JCO.2004.22.14_SUPPL.7005